Lysine Methylation Promotes VEGFR-2 Activation and Angiogenesis
Edward J. Hartsough, Rosana D. Meyer, Vipul Chitalia, Yan Jiang, Victor E. Marquez, Irina V. Zhdanova, Janice Weinberg, Catherine E. Costello and Nader Rahimi
Activation of vascular endothelial growth factor receptor-2 (VEGFR-2), an endothelial cell receptor tyrosine kinase, promotes tumor angiogenesis and ocular neovascularization. We report the methylation of VEGFR-2 at multiple Lys and Arg residues, including Lys1041, a residue that is proximal to the activation loop of the kinase domain. Methylation of VEGFR-2 was independent of ligand binding and was not regulated by ligand stimulation. Methylation of Lys1041 enhanced tyrosine phosphorylation and kinase activity in response to ligands. Additionally, interfering with the methylation of VEGFR-2 by pharmacological inhibition or by site-directed mutagenesis revealed that methylation of Lys1041 was required for VEGFR-2-mediated angiogenesis in zebrafish and tumor growth in mice. We propose that methylation of Lys1041 promotes the activation of VEGFR-2 and that similar posttranslational modification could also regulate the activity of other receptor tyrosine kinases.
Lysine Methylation Promotes VEGFR-2 Activation and Angiogenesis
Creators
Edward J. Hartsough - Boston University
Rosana D. Meyer - Boston University
Vipul Chitalia - Harvard–MIT Division of Health Sciences and Technology
Yan Jiang - Boston University
Victor E. Marquez - Frederick National Laboratory for Cancer Research
Irina V. Zhdanova - Boston Medical Center
Janice Weinberg - Boston University
Catherine E. Costello - Boston University
Nader Rahimi - Boston University
Publication Details
Science signaling, v 6(304), pp ra104-ra104
Publisher
Amer Assoc Advancement Science
Number of pages
7
Grant note
N01 HHSN268201000031C / NIH/National Heart, Lung, and Blood Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)
DK080946 / K08 award (NIH/National Institute of Diabetes and Digestive and Kidney Diseases)
K08DK080946 / NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
R01EY017955; P41 RR010888/GM104603; S10 RR020946 / NIH/National Eye Institute; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)
Massachusetts Lions Foundation
S10RR020946 / NATIONAL CENTER FOR RESEARCH RESOURCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Center for Research Resources (NCRR)
Department of Pathology, Boston University
Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)
P41GM104603 / NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS)
K08 award (Department of Medicine Career Investment Award)
R01EY017955 / NATIONAL EYE INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)
Resource Type
Journal article
Language
English
Academic Unit
Pharmacology and Physiology
Web of Science ID
WOS:000327941400002
Scopus ID
2-s2.0-84889238946
Other Identifier
991020531971004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: